In the first of his two-part article Chris Jennings identifies the false assumptions in HIV / AIDS incidence estimates that may have lead to a gross overestimation of the disease. The situation with the African HIV/AIDS epidemic is analogous to that of the global finance crisis. Thousands of diligent people are...
Sanofi is still plugging away with its oral BTK inhibitor tolebrutinib in multiple sclerosis, but has decided to abandon efforts to develop the drug for neuromuscular diso
In the newest episode of the pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Jameka Hill, senior director of clinical trial health equity at Moderna.